Regarding: Huntington GR, Pennington JM. Fatal Methaemoglobinaemia Due To Intentional Sodium Nitrite Poisoning. Acute Med. 2021; 20(2):148-150
Huntington and Pennington’s recent article1 on a case of Fatal Methaeglobinaemia Due To Intentional Sodium Nitrate Poisoning was very interesting, is a useful overview of initial diagnosis and management, and has helped remind the readers of this potentially life-threatening condition.
We somewhat disagree with their interpretation that 15% methaemoglobin (metHb) with haemoglobin (Hb) 160 g/L represents a greater quantity of abnormal haemoglobin than 20% metHb with Hb 80 g/L for example, and may produce a more severe clinical picture.
In our opinion, Ludlow’s definition where the percentage of metHb is calculated by dividing the concentration of metHb by the concentration of total Hb is more accurate. The percentage of metHb is likely to be a better indicator of illness severity than overall concentration, as although the metHb may interfere with the normal Hb, it is the absolute normal Hb concentration that will determine symptoms including breathlessness. 2
In addition to methylene blue, which can, itself, cause methaemoglobinaemia, there are some other treatments to consider if methylene blue is not effective, not available or contraindicated. These include, repeat methylCYP450 inhibitors (e.g. cimetidine) or exchange transfusion. Individuals with G6PD deficiency may not produce sufficient NADPH to reduce methylene blue to leukomethylene blue, potentially rendering the therapy ineffective. Furthermore, methylene blue might induce haemolysis in G6PD-deficient patients, therefore, in these patients, alternative treatment with cimetidine or possibly ascorbic acid or exchange transfusions should be considered.3
References:
Huntington GR, Pennington JM. Fatal Methaemoglobinaemia Due To Intentional Sodium Nitrite Poisoning. Acute Med. 2021; 20(2):148-150. https://doi.org/10.52964/AMJA.0856
Al-Lawati A, Murch N. Acquired Methemoglobinaemia. Sultan Qaboos Univ Med J. 2012;12(2):237-241. https://doi.org/10.12816/0003120
Huntington and Pennington’s recent article1 on a case of Fatal Methaeglobinaemia Due To Intentional Sodium Nitrate Poisoning was very interesting, is a useful overview of initial diagnosis and management, and has helped remind the readers of this potentially life-threatening condition.
We somewhat disagree with their interpretation that 15% methaemoglobin (metHb) with haemoglobin (Hb) 160 g/L represents a greater quantity of abnormal haemoglobin than 20% metHb with Hb 80 g/L for example, and may produce a more severe clinical picture.
In our opinion, Ludlow’s definition where the percentage of metHb is calculated by dividing the concentration of metHb by the concentration of total Hb is more accurate. The percentage of metHb is likely to be a better indicator of illness severity than overall concentration, as although the metHb may interfere with the normal Hb, it is the absolute normal Hb concentration that will determine symptoms including breathlessness. 2
In addition to methylene blue, which can, itself, cause methaemoglobinaemia, there are some other treatments to consider if methylene blue is not effective, not available or contraindicated. These include, repeat methylCYP450 inhibitors (e.g. cimetidine) or exchange transfusion. Individuals with G6PD deficiency may not produce sufficient NADPH to reduce methylene blue to leukomethylene blue, potentially rendering the therapy ineffective. Furthermore, methylene blue might induce haemolysis in G6PD-deficient patients, therefore, in these patients, alternative treatment with cimetidine or possibly ascorbic acid or exchange transfusions should be considered.3
References:
Huntington GR, Pennington JM. Fatal Methaemoglobinaemia Due To Intentional Sodium Nitrite Poisoning. Acute Med. 2021; 20(2):148-150. https://doi.org/10.52964/AMJA.0856
To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center’s (CCC) Marketplace website by clicking the button below:
Ariyo M, Murch N, Al-Lawati A. Letters to Editor. Acute Med. 2021;20(4):304. doi: 10.52964/AMJA.0884. PMID: 35072392.
Letters to Editor
Share this article
Click the icon of the social media platform on which you would like to share this article.
Shopping Basket
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. For more information, please visit our privacy and cookies policy.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.